Avior Wealth Management’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-24
Closed -$178 2190
2024
Q4
$178 Hold
24
﹤0.01% 2381
2024
Q3
$139 Hold
24
﹤0.01% 2244
2024
Q2
$159 Sell
24
-147
-86% -$1.19K ﹤0.01% 2192
2024
Q1
$2.23K Buy
+171
New +$2.28K ﹤0.01% 2256

Other funds holding TMCI

Avior Wealth Management's TMCI Position: Q1 2025 in Review

Avior Wealth Management sold out of Treace Medical Concepts (TMCI) in Q1 2025, closing a stake of 24 shares — an estimated $178 sold.

Avior Wealth Management first reported a position in TMCI in Q1 2024 and held it in 4 quarters. The position peaked at $2.23K in Q1 2024. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

  • Avior Wealth Management reported no remaining Treace Medical Concepts position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 24 Treace Medical Concepts shares in Q1 2025, an estimated $178.
  • Avior Wealth Management first reported a position in Treace Medical Concepts in Q1 2024 and held it in 4 quarters.
  • Avior Wealth Management's Treace Medical Concepts position peaked at $2.23K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.